Zhejiang Medicine Co Ltd (600216) — Cash Flow-to-Debt Ratio
Zhejiang Medicine Co Ltd (600216) has a Cash Flow-to-Debt Ratio of 0.24x as of September 2025, meaning its operating cash flow of CN¥690.77 Million could theoretically repay 0% of its total liabilities (CN¥2.92 Billion) in one year. See free cash flow generation of Zhejiang Medicine Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Medicine Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Zhejiang Medicine Co Ltd across 28 annual periods. Also explore 600216 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Zhejiang Medicine Co Ltd. For market capitalisation and broader financial context, see Zhejiang Medicine Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.63x | CN¥1.89 Billion | CN¥3.00 Billion | ▲ +50.3% |
| 2024 | 0.42x | CN¥1.22 Billion | CN¥2.93 Billion | ▲ +84.0% |
| 2023 | 0.23x | CN¥634.31 Million | CN¥2.79 Billion | ▲ +18.8% |
| 2022 | 0.19x | CN¥520.60 Million | CN¥2.72 Billion | ▼ -43.6% |
| 2021 | 0.34x | CN¥1.14 Billion | CN¥3.35 Billion | ▼ -33.3% |
| 2020 | 0.51x | CN¥1.26 Billion | CN¥2.47 Billion | ▲ +140.0% |
| 2019 | 0.21x | CN¥447.25 Million | CN¥2.11 Billion | ▼ -28.2% |
| 2018 | 0.30x | CN¥579.91 Million | CN¥1.96 Billion | ▲ +18.1% |
| 2017 | 0.25x | CN¥503.47 Million | CN¥2.01 Billion | ▲ +35.5% |
| 2016 | 0.18x | CN¥336.14 Million | CN¥1.82 Billion | ▲ +182.8% |
| 2015 | 0.07x | CN¥106.54 Million | CN¥1.63 Billion | ▼ -84.5% |
| 2014 | 0.42x | CN¥549.90 Million | CN¥1.31 Billion | ▼ -30.9% |
| 2013 | 0.61x | CN¥655.09 Million | CN¥1.08 Billion | ▼ -35.1% |
| 2012 | 0.94x | CN¥807.49 Million | CN¥860.73 Million | ▼ -17.9% |
| 2011 | 1.14x | CN¥912.75 Million | CN¥798.63 Million | ▼ -32.8% |
| 2010 | 1.70x | CN¥1.32 Billion | CN¥773.86 Million | ▲ +18.2% |
| 2009 | 1.44x | CN¥1.47 Billion | CN¥1.02 Billion | ▲ +74.1% |
| 2008 | 0.83x | CN¥1.20 Billion | CN¥1.45 Billion | ▲ +615.4% |
| 2007 | 0.12x | CN¥227.67 Million | CN¥1.97 Billion | ▲ +19.3% |
| 2006 | 0.10x | CN¥169.51 Million | CN¥1.75 Billion | ▲ +468.1% |
| 2005 | 0.02x | CN¥25.14 Million | CN¥1.48 Billion | ▼ -81.1% |
| 2004 | 0.09x | CN¥107.60 Million | CN¥1.19 Billion | ▲ +41.7% |
| 2003 | 0.06x | CN¥66.20 Million | CN¥1.04 Billion | ▲ +177.1% |
| 2002 | 0.02x | CN¥23.13 Million | CN¥1.01 Billion | ▼ -77.6% |
| 2001 | 0.10x | CN¥98.25 Million | CN¥956.66 Million | ▲ +677.9% |
| 2000 | 0.01x | CN¥10.58 Million | CN¥801.61 Million | ▲ +127.9% |
| 1999 | -0.05x | CN¥-51.90 Million | CN¥1.10 Billion | ▼ -164.3% |
| 1998 | 0.07x | CN¥57.72 Million | CN¥782.87 Million | — |